Original ArticlesThe Use of Extracorporeal Membrane Oxygenation as a Bridge to Bone Marrow Transplantation in a Patient With High-risk Acute Myeloid LeukemiaNader, Marie MD*; Bonde, Pramod MD†; Massaro, Stephanie MD, MPH‡; Giuliano, John S. Jr MD§; Shah, Niketa MD‡ Author Information *Department of Pediatrics, Section of Critical Care Medicine, Yale New Haven Children’s Hospital †Department of Surgery, Section of Cardiac Surgery ‡Department of Pediatrics, Section of Pediatric Hematology and Oncology §Department of Pediatrics, Section of Critical Care Medicine, Yale University School of Medicine, New Haven, CT The authors declare no conflict of interest Reprints: Marie Nader, MD, Department of Pediatrics, Yale University, 333 Cedar Street, PO Box 208064 New Haven, CT 06520-8064 (e-mail: [email protected]). Journal of Pediatric Hematology/Oncology 45(1):p 18-20, January 2023. | DOI: 10.1097/MPH.0000000000002567 Buy Metrics Abstract An 18-year-old girl with high-risk acute myeloid leukemia developed Streptococcus mitis septic shock and multiorgan dysfunction syndrome, including biventricular failure. Due to the anticipated reversibility of her cardiogenic shock, her young age, and her favorable survival chance after an allogeneic hematopoietic stem cell transplant, she was placed on full circulatory support with venoarterial extracorporeal membrane oxygenation as a bridge to her successful hematopoietic stem cell transplantation 2 months later. This highlights the importance of prognostication in patient selection for extracorporeal life support. A multidisciplinary approach is essential to each case until more definite initiation criteria, risk stratification, and treatment protocols are established. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.